|
 | Up a level |
Jitender, . and Vikram Kumar, B and Singh, S and Verma, G and Kumar, R and Mishra, PM and Kumar, S and Nagaraj, SK and Nag, J and Joy, CM and Nikam, B and Singh, D and Pooja, . and Kalidas, N and Singh, S and Mumtaz, . and Bhardwaj, AK and Mankotia, DS and Ringe, RP and Gupta, N and Tripathi, S and Mishra, RPN (2024) Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster. In: Vaccine, 42 (20).
Mittal, N and Kumar, S and Rajmani, RS and Singh, R and Lemoine, C and Jakob, V and Bj, S and Jagannath, N and Bhat, M and Chakraborty, D and Pandey, S and Jory, A and Sa, SS and Kleanthous, H and Dubois, P and Ringe, RP and Varadarajan, R (2023) Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants. In: npj Vaccines, 8 (1).
Kumar, N and Taily, IM and Singh, C and Kumar, S and Rajmani, RS and Chakraborty, D and Sharma, A and Singh, P and Thakur, KG and Varadarajan, R and Ringe, RP and Banerjee, P and Banerjee, I (2023) Identification of diphenylurea derivatives as novel endocytosis inIdentification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivohibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. In: PLoS Pathogens, 19 (5).
Khan, MS and Jakob, V and Singh, R and Rajmani, RS and Kumar, S and Lemoine, C and Kleanthous, H and Ringe, RP and Dubois, PM and Varadarajan, R (2023) Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. In: Pharmaceutics, 15 (12).
Ahmed, S and Khan, MS and Gayathri, S and Singh, R and Kumar, S and Patel, UR and Malladi, SK and Rajmani, RS and van Vuren, PJ and Riddell, S and Goldie, S and Girish, N and Reddy, P and Upadhyaya, A and Pandey, S and Siddiqui, S and Tyagi, A and Jha, S and Pandey, R and Khatun, O and Narayan, R and Tripathi, S and McAuley, AJ and Singanallur, NB and Vasan, SS and Ringe, RP and Varadarajan, R (2021) A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern. In: Frontiers in Immunology, 12 .
Malladi, SK and Patel, UR and Rajmani, RS and Singh, R and Pandey, S and Kumar, S and Khaleeq, S and Van Vuren, PJ and Riddell, S and Goldie, S and Gayathri, S and Chakraborty, D and Kalita, P and Pramanick, I and Agarwal, N and Reddy, P and Girish, N and Upadhyaya, A and Khan, MS and Kanjo, K and Bhat, M and Mani, S and Bhattacharyya, S and Siddiqui, S and Tyagi, A and Jha, S and Pandey, R and Tripathi, S and Dutta, S and McAuley, AJ and Singanallur, NB and Vasan, SS and Ringe, RP and Varadarajan, R (2021) Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative. In: ACS Infectious Diseases .
